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This month, on November 12, the world will recog-nize the fourth annual World Pneumonia Day. First 
launched in 2009 by a coalition of global health leaders 
(1), World Pneumonia Day aims to raise awareness about 
pneumonia’s toll on the world’s children and to promote 
interventions to protect against, treat, and prevent the dis-
ease. Pneumonia continues to be the leading killer of young 
children around the world, causing ≈14% of all deaths in 
children 1 month to 5 years of age (2). It is a critical disease 
for countries to conquer in order to reach Millennium De-
velopment Goal 4: reducing the child mortality rate by two 
thirds from 1990 to 2015 (3). Most children who die from 
pneumonia live in developing countries, where such fac-
tors as malnutrition, crowding, and lack of access to quality 
health care increase the risk for death. Pneumonia kills few 
children in industrialized countries, although it remains 
among the top 10 causes of deaths in the United States, for 
example, because of deaths in older adults (4).
Fortunately, many interventions are now available to 
reduce deaths due to pneumonia among children through-
out the world. On the fi rst World Pneumonia Day in 2009, 
the World Health Organization and the United Nations 
Children’s Fund, together with many global experts and 
partners, launched the Global Action Plan for Prevention 
and Control of Pneumonia (GAPP) (5). GAPP recommends 
a strategy of prevention, protection, and treatment that is 
designed to implement readily available interventions that 
can reduce pneumonia deaths in children. GAPP focuses on 
improving nutrition (through measures such as exclusive 
breastfeeding), increasing access to vaccines that protect 
from agents that cause pneumonia (such as Haemphilus 
infl uenzae type b and pneumococcal vaccines), reducing 
exposure to indoor air pollution, and increasing access to 
antimicrobial drugs that can treat pneumonia.
In 2010, the World Health Assembly passed a reso-
lution recognizing the role of pneumonia as the leading 
cause of deaths in children, setting out the goal of reducing 
pneumonia deaths as a global health priority (6), and the 
World Health Organization began tracking implementation 
of GAPP. One notable area of success has been the intro-
duction of new vaccines to prevent pneumonia. During the 
last few years, because of funding and technical support 
from the Global Alliance for Vaccines and Immunizations 
and various partners, the introduction of new vaccines in 
developing countries has had unprecedented momentum. 
Haemophilus infl uenzae type b vaccines have been intro-
duced or are ready to be introduced in all countries eligible 
for Global  Alliance for Vaccines and Immunizations  fund-
ing by 2013, and pneumococcal conjugate vaccines are ex-
pected to be introduced in 54 countries by 2015 (7).
Despite recent progress in the effort to decrease the 
number of pneumonia cases, pneumonia is still an urgent 
problem. This month’s issue of Emerging Infectious Dis-
eases presents results of recent research on pneumonia con-
ducted around the world. The work, mostly from high-in-
come settings, highlights some of the remaining diffi culties 
involving pneumonia prevention, treatment, and control. 
For example, although van Deursen et al. show the remark-
able benefi ts of the pneumococcal conjugate vaccination 
program in the Netherlands (8), Fleming-Dutra et al. report 
how pneumococcal pneumonia outbreaks can occur even in 
a highly vaccinated population if crowding and poor health 
are common, because currently available vaccines do not 
cover all pneumococcal serotypes (9). By describing cases 
of pneumonia that occurred after the megaquake in Japan 
in 2011, Takahashi et al. show how natural disasters might 
lead to increases in pneumonia risk or create large shifts in 
needed health care (10).
Many challenging research questions remain. A recent 
priority-setting exercise outlined the most urgent studies 
needed to reduce pneumonia deaths in low-income coun-
tries (11). Priority items ranged from assessments of vac-
cine effects on disease in low-income settings to evaluation 
of measures to improve community management of pneu-
monia. In addition, a large, multicenter study to identify 
the etiologic agents of pneumonia in developing countries, 
supported by the Bill and Melinda Gates Foundation, was 
launched in 2011 (12). This study is expected to generate 
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data that will better guide prevention and treatment strate-
gies, particularly in countries that are already using new 
vaccines.
This November 12, World Pneumonia Day, we urge 
the global community to consider the massive problems 
of pneumonia. Better yet, take a moment to consider what 
you can do to solve this problem. Health care providers, 
researchers, policy makers, and the greater public health 
community all need to contribute if we are to make rapid, 
substantial progress toward reducing disease and deaths 
due to pneumonia. Progress is being made, but much more 
can be done.
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